LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 393

Search options

  1. Article ; Online: A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patients.

    Lee, Valerie / Parkinson, Rose / Zahurak, Marianna / Cope, Leslie / Cercek, Andrea / Verheul, Henk / Gootjes, Elske / Lenz, Heinz Josef / Iqbal, Syma / Jones, Peter / Baylin, Stephen / Rami, Vandna / Ahuja, Nita / El Khoueiry, Anthony / Azad, Nilofer S

    International journal of cancer

    2024  Volume 154, Issue 10, Page(s) 1794–1801

    Abstract: ... 102 (Arm B) on a 28-day cycle. Between January 15, 2016 and October 24, 2018, 104 pts were randomized ... at four international sites, with 96 pts undergoing treatment, 62 in Arm A and 34 in Arm B. Median overall ... survival was 7.15 months for Arm A and 7.66 months for Arm B (HR 0.93, 95% CI: 0.58-1.47, P = .75 ...

    Abstract DNA methyltransferase inhibitors (DNMTi) have demonstrated benefit in reversing resistance to systemic therapies for several cancer types. In a phase II trial of guadecitabine and irinotecan compared to regorafenib or TAS-102 in pts with advanced mCRC refractory to irinotecan. Patients with mCRC refractory to irinotecan were randomized 2:1 to guadecitabine and irinotecan (Arm A) vs standard of care regorafenib or TAS-102 (Arm B) on a 28-day cycle. Between January 15, 2016 and October 24, 2018, 104 pts were randomized at four international sites, with 96 pts undergoing treatment, 62 in Arm A and 34 in Arm B. Median overall survival was 7.15 months for Arm A and 7.66 months for Arm B (HR 0.93, 95% CI: 0.58-1.47, P = .75). The Kaplan-Meier rates of progression free survival at 4 months were 32% in Arm A and 26% in Arm B. Common ≥Grade 3 treatment related adverse events in Arm A were neutropenia (42%), anemia (18%), diarrhea (11%), compared to Arm B pts with neutropenia (12%), anemia (12%). Guadecitabine and irinotecan had similar OS compared to standard of care TAS-102 or regorafenib, with evidence of target modulation. Clinical trial information: NCT01896856.
    MeSH term(s) Humans ; Irinotecan/therapeutic use ; Colorectal Neoplasms/pathology ; Treatment Outcome ; Colonic Neoplasms/drug therapy ; Rectal Neoplasms/drug therapy ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Neutropenia ; Anemia/drug therapy ; Thymine ; Trifluridine ; Azacitidine/analogs & derivatives ; Phenylurea Compounds ; Drug Combinations ; Pyrrolidines ; Pyridines
    Chemical Substances Irinotecan (7673326042) ; trifluridine tipiracil drug combination ; guadecitabine (2KT4YN1DP7) ; regorafenib (24T2A1DOYB) ; Thymine (QR26YLT7LT) ; Trifluridine (RMW9V5RW38) ; Azacitidine (M801H13NRU) ; Phenylurea Compounds ; Drug Combinations ; Pyrrolidines ; Pyridines
    Language English
    Publishing date 2024-02-05
    Publishing country United States
    Document type Randomized Controlled Trial ; Clinical Trial, Phase II ; Journal Article
    ZDB-ID 218257-9
    ISSN 1097-0215 ; 0020-7136
    ISSN (online) 1097-0215
    ISSN 0020-7136
    DOI 10.1002/ijc.34845
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: "APUD" cells: fact and fiction.

    Baylin, S B

    Trends in endocrinology and metabolism: TEM

    2008  Volume 1, Issue 4, Page(s) 198–204

    Abstract: Pearse's "APUD" cell theory helps define the ontogeny and differentiation programs of small polypeptide hormone-secreting cells of diverse tissue origins. Cells with such features may arise through one of multiple related pathways of epithelial cell ... ...

    Abstract Pearse's "APUD" cell theory helps define the ontogeny and differentiation programs of small polypeptide hormone-secreting cells of diverse tissue origins. Cells with such features may arise through one of multiple related pathways of epithelial cell differentiation ongoing in tissues of all embryonic lineages.
    Language English
    Publishing date 2008-01-31
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1042384-9
    ISSN 1879-3061 ; 1043-2760
    ISSN (online) 1879-3061
    ISSN 1043-2760
    DOI 10.1016/1043-2760(90)90053-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Associations of bacterial enteropathogens with systemic inflammation, iron deficiency, and anemia in preschool-age children in southern Ghana.

    Lambrecht, Nathalie J / Bridges, Dave / Wilson, Mark L / Adu, Bright / Eisenberg, Joseph N S / Folson, Gloria / Baylin, Ana / Jones, Andrew D

    PloS one

    2022  Volume 17, Issue 7, Page(s) e0271099

    Abstract: Anemia remains a pervasive public health problem among preschool-age children in Ghana. Recent analyses have found that anemia in Ghanaian children, particularly in Southern regions, is largely attributable to infectious causes, rather than nutritional ... ...

    Abstract Anemia remains a pervasive public health problem among preschool-age children in Ghana. Recent analyses have found that anemia in Ghanaian children, particularly in Southern regions, is largely attributable to infectious causes, rather than nutritional factors. Infections with enteropathogens can reduce iron absorption and increase systemic inflammation, but few studies have examined direct links between enteropathogens and anemia. This study investigated associations between detection of individual bacterial enteropathogens and systemic inflammation, iron deficiency, and anemia among 6- to 59-month-old children in Greater Accra, Ghana. Serum samples were analyzed from a cross-sectional sample of 262 children for concentrations of hemoglobin (Hb), biomarkers of systemic inflammation [C-reactive protein (CRP) and α-1-acid glycoprotein (AGP)], and biomarkers of iron status [serum ferritin (SF) and serum transferrin receptor (sTfR)]. Stool samples were analyzed for ten bacterial enteropathogens using qPCR. We estimated associations between presence of each enteropathogen and elevated systemic inflammation (CRP > 5 mg/L and AGP > 1 g/L), iron deficiency (SF < 12 μg/L and sTfR > 8.3 mg/L) and anemia (Hb < 110 g/L). Enteropathogens were detected in 87% of children's stool despite a low prevalence of diarrhea (6.5%). Almost half (46%) of children had anemia while one-quarter (24%) had iron deficiency (low SF). Despite finding no associations with illness symptoms, Campylobacter jejuni/coli detection was strongly associated with elevated CRP [Odds Ratio (95% CI): 3.49 (1.45, 8.41)] and elevated AGP [4.27 (1.85, 9.84)]. Of the pathogens examined, only enteroinvasive Escherichia coli/Shigella spp. (EIEC/Shigella) was associated with iron deficiency, and enteroaggregative Escherichia coli (EAEC) [1.69 (1.01, 2.84)] and EIEC/Shigella [2.34 (1.15, 4.76)] were associated with anemia. These results suggest that certain enteroinvasive pathogenic bacteria may contribute to child anemia. Reducing exposure to enteropathogens through improved water, sanitation, and hygiene practices may help reduce the burden of anemia in young Ghanaian children.
    MeSH term(s) Anemia/epidemiology ; Anemia, Iron-Deficiency/complications ; Anemia, Iron-Deficiency/epidemiology ; Bacteria/metabolism ; Biomarkers ; C-Reactive Protein/metabolism ; Child ; Child, Preschool ; Cross-Sectional Studies ; Ferritins ; Ghana/epidemiology ; Hemoglobins/metabolism ; Humans ; Infant ; Inflammation ; Iron/metabolism ; Iron Deficiencies
    Chemical Substances Biomarkers ; Hemoglobins ; C-Reactive Protein (9007-41-4) ; Ferritins (9007-73-2) ; Iron (E1UOL152H7)
    Language English
    Publishing date 2022-07-08
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0271099
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Tissue-location-specific transcription programs drive tumor dependencies in colon cancer.

    Yang, Lijing / Tu, Lei / Bisht, Shilpa / Mao, Yiqing / Petkovich, Daniel / Thursby, Sara-Jayne / Liang, Jinxiao / Patel, Nibedita / Yen, Ray-Whay Chiu / Largent, Tina / Zahnow, Cynthia / Brock, Malcolm / Gabrielson, Kathy / Salimian, Kevan J / Baylin, Stephen B / Easwaran, Hariharan

    Nature communications

    2024  Volume 15, Issue 1, Page(s) 1384

    Abstract: Cancers of the same tissue-type but in anatomically distinct locations exhibit different molecular dependencies for tumorigenesis. Proximal and distal colon cancers exemplify such characteristics, with ... ...

    Abstract Cancers of the same tissue-type but in anatomically distinct locations exhibit different molecular dependencies for tumorigenesis. Proximal and distal colon cancers exemplify such characteristics, with BRAF
    MeSH term(s) Humans ; Mice ; Animals ; Proto-Oncogene Proteins B-raf/genetics ; CDX2 Transcription Factor/genetics ; Colonic Neoplasms/genetics ; Colonic Neoplasms/pathology ; DNA-Binding Proteins ; Transcription Factors/genetics ; Homeodomain Proteins/genetics
    Chemical Substances Proto-Oncogene Proteins B-raf (EC 2.7.11.1) ; CDX2 Transcription Factor ; DNA-Binding Proteins ; Transcription Factors ; Homeodomain Proteins
    Language English
    Publishing date 2024-02-15
    Publishing country England
    Document type Journal Article
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-024-45605-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Transcription factor expression repertoire basis for epigenetic and transcriptional subtypes of colorectal cancers.

    Bhandari, Yuba R / Krishna, Vinod / Powers, Rachael / Parmar, Sehej / Thursby, Sara-Jayne / Gupta, Ekta / Kulak, Ozlem / Gokare, Prashanth / Reumers, Joke / Van Wesenbeeck, Liesbeth / Bachman, Kurtis E / Baylin, Stephen B / Easwaran, Hariharan

    Proceedings of the National Academy of Sciences of the United States of America

    2023  Volume 120, Issue 31, Page(s) e2301536120

    Abstract: Colorectal cancers (CRCs) form a heterogenous group classified into epigenetic and transcriptional subtypes. The basis for the epigenetic subtypes, exemplified by varying degrees of promoter DNA hypermethylation, and its relation to the transcriptional ... ...

    Abstract Colorectal cancers (CRCs) form a heterogenous group classified into epigenetic and transcriptional subtypes. The basis for the epigenetic subtypes, exemplified by varying degrees of promoter DNA hypermethylation, and its relation to the transcriptional subtypes is not well understood. We link cancer-specific transcription factor (TF) expression alterations to methylation alterations near TF-binding sites at promoter and enhancer regions in CRCs and their premalignant precursor lesions to provide mechanistic insights into the origins and evolution of the CRC molecular subtypes. A gradient of TF expression changes forms a basis for the subtypes of abnormal DNA methylation, termed CpG-island promoter DNA methylation phenotypes (CIMPs), in CRCs and other cancers. CIMP is tightly correlated with cancer-specific hypermethylation at enhancers, which we term CpG-enhancer methylation phenotype (CEMP). Coordinated promoter and enhancer methylation appears to be driven by downregulation of TFs with common binding sites at the hypermethylated enhancers and promoters. The altered expression of TFs related to hypermethylator subtypes occurs early during CRC development, detectable in premalignant adenomas. TF-based profiling further identifies patients with worse overall survival. Importantly, altered expression of these TFs discriminates the transcriptome-based consensus molecular subtypes (CMS), thus providing a common basis for CIMP and CMS subtypes.
    MeSH term(s) Humans ; Transcription Factors ; Gene Expression Regulation ; DNA Methylation ; Precancerous Conditions ; Colorectal Neoplasms ; Epigenesis, Genetic
    Chemical Substances Transcription Factors
    Language English
    Publishing date 2023-07-24
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.2301536120
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia.

    Baer, Maria R / Kogan, Aksinija A / Bentzen, Søren M / Mi, Tian / Lapidus, Rena G / Duong, Vu H / Emadi, Ashkan / Niyongere, Sandrine / O'Connell, Casey L / Youngblood, Benjamin A / Baylin, Stephen B / Rassool, Feyruz V

    Clinical cancer research : an official journal of the American Association for Cancer Research

    2022  Volume 28, Issue 7, Page(s) 1313–1322

    Abstract: ... 25 patients, including 22 previously treated with DNMTi(s)] to a recommended phase II dose ...

    Abstract Purpose: Patients with acute myeloid leukemia (AML) unfit for, or resistant to, intensive chemotherapy are often treated with DNA methyltransferase inhibitors (DNMTi). Novel combinations may increase efficacy. In addition to demethylating CpG island gene promoter regions, DNMTis enhance PARP1 recruitment and tight binding to chromatin, preventing PARP-mediated DNA repair, downregulating homologous recombination (HR) DNA repair, and sensitizing cells to PARP inhibitor (PARPi). We previously demonstrated DNMTi and PARPi combination efficacy in AML in vitro and in vivo. Here, we report a phase I clinical trial combining the DNMTi decitabine and the PARPi talazoparib in relapsed/refractory AML.
    Patients and methods: Decitabine and talazoparib doses were escalated using a 3 + 3 design. Pharmacodynamic studies were performed on cycle 1 days 1 (pretreatment), 5 and 8 blood blasts.
    Results: Doses were escalated in seven cohorts [25 patients, including 22 previously treated with DNMTi(s)] to a recommended phase II dose combination of decitabine 20 mg/m2 intravenously daily for 5 or 10 days and talazoparib 1 mg orally daily for 28 days, in 28-day cycles. Grade 3-5 events included fever in 19 patients and lung infections in 15, attributed to AML. Responses included complete remission with incomplete count recovery in two patients (8%) and hematologic improvement in three. Pharmacodynamic studies showed the expected DNA demethylation, increased PARP trapping in chromatin, increased γH2AX foci, and decreased HR activity in responders. γH2AX foci increased significantly with increasing talazoparib doses combined with 20 mg/m2 decitabine.
    Conclusions: Decitabine/talazoparib combination was well tolerated. Expected pharmacodynamic effects occurred, especially in responders.
    MeSH term(s) Antineoplastic Combined Chemotherapy Protocols ; Azacitidine ; DNA ; Decitabine/therapeutic use ; Humans ; Leukemia, Myeloid, Acute/drug therapy ; Methyltransferases ; Phthalazines ; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use
    Chemical Substances Phthalazines ; Poly(ADP-ribose) Polymerase Inhibitors ; Decitabine (776B62CQ27) ; DNA (9007-49-2) ; talazoparib (9QHX048FRV) ; Methyltransferases (EC 2.1.1.-) ; Azacitidine (M801H13NRU)
    Language English
    Publishing date 2022-01-28
    Publishing country United States
    Document type Clinical Trial, Phase I ; Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1225457-5
    ISSN 1557-3265 ; 1078-0432
    ISSN (online) 1557-3265
    ISSN 1078-0432
    DOI 10.1158/1078-0432.CCR-21-3729
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Associations between livestock ownership and lower odds of anaemia among children 6-59 months old are not mediated by animal-source food consumption in Ghana.

    Lambrecht, Nathalie J / Wilson, Mark L / Baylin, Ana / Folson, Gloria / Naabah, Samuel / Eisenberg, Joseph N S / Adu, Bright / Jones, Andrew D

    Maternal & child nutrition

    2021  Volume 17, Issue 3, Page(s) e13163

    Abstract: Livestock ownership may mitigate anaemia among young children by providing access to animal-source foods (ASFs) yet exacerbate anaemia by exposing children to animal-source pathogens. This study aimed to assess the association between household livestock ...

    Abstract Livestock ownership may mitigate anaemia among young children by providing access to animal-source foods (ASFs) yet exacerbate anaemia by exposing children to animal-source pathogens. This study aimed to assess the association between household livestock ownership and child anaemia and examine whether this relationship is mediated by child ASF consumption or by child morbidity and inflammation. We conducted a cross-sectional study of 470 children aged 6-59 months in Greater Accra, Ghana. Child blood samples were analysed for haemoglobin concentration, iron status biomarkers and inflammatory biomarkers. Caregivers were asked about the child's frequency of ASF consumption in the past 3 months. Livestock ownership was categorized into five typologies to distinguish households by the number and combinations of species owned. In adjusted logistic regression, children from households in Type 5, owning cattle, small livestock (goats, sheep or pigs) and poultry, had lower odds of anaemia compared with those in Type 1, owning no livestock (OR [95% CI]: 0.32 [0.14, 0.71]). Although children from households that owned poultry were more likely to consume chicken meat, and children from households with cattle were more likely to drink cow's milk, consumption of these ASFs did not mediate the observed association between livestock ownership and child anaemia. There were no associations between livestock ownership and children's symptoms of illness or inflammation. Further research is needed to understand how ownership of certain livestock species, or a greater diversity of livestock species, may be associated with the risk of child anaemia, including the role of dietary and income-based pathways.
    MeSH term(s) Anemia/epidemiology ; Animals ; Cattle ; Child ; Child, Preschool ; Cross-Sectional Studies ; Ghana/epidemiology ; Humans ; Infant ; Livestock ; Ownership ; Sheep ; Swine
    Language English
    Publishing date 2021-03-01
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2175105-5
    ISSN 1740-8709 ; 1740-8695
    ISSN (online) 1740-8709
    ISSN 1740-8695
    DOI 10.1111/mcn.13163
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Ruminant-Related Risk Factors are Associated with Shiga Toxin-Producing Escherichia coli Infection in Children in Southern Ghana.

    Lambrecht, Nathalie J / Wilson, Mark L / Bridges, Dave / Eisenberg, Joseph N S / Adu, Bright / Baylin, Ana / Folson, Gloria / Jones, Andrew D

    The American journal of tropical medicine and hygiene

    2021  Volume 106, Issue 2, Page(s) 513–522

    Abstract: Livestock can provide benefits to low-income households, yet may expose children to zoonotic enteropathogens that cause illness and negative long-term health outcomes. The aim of this cross-sectional study was to determine whether livestock-related risk ... ...

    Abstract Livestock can provide benefits to low-income households, yet may expose children to zoonotic enteropathogens that cause illness and negative long-term health outcomes. The aim of this cross-sectional study was to determine whether livestock-related risk factors, including animal ownership, exposure to animal feces, and consumption of animal-source foods, were associated with bacterial zoonotic enteropathogen infections in children 6-59 months old in Greater Accra, Ghana. Stool samples from 259 children and 156 household chickens were analyzed for atypical enteropathogenic Escherichia coli (aEPEC), Campylobacter jejuni/coli (C. jejuni/coli), Salmonella, and Shiga toxin-producing Escherichia coli (STEC) using quantitative polymerase chain reaction (qPCR). aEPEC, C. jejuni/coli, STEC, and Salmonella were detected in 45.6%, 11.6%, 4.3%, and 0.8% of children's stool samples, respectively. In adjusted logistic regression models, household ownership of goats or sheep was associated with STEC detection in children (odds ratio [95% confidence interval]: 4.30 [1.32, 14.08]), as were positive detection of STEC in chicken feces (7.85 [2.54, 24.30]) and frequent consumption of fresh cow's milk (3.03 [1.75, 5.24]). No livestock-related risk factors were associated with aEPEC or C. jejuni/coli infection in children. Our findings suggest that ruminant ownership in southern Ghana may expose children to STEC through household fecal contamination and foodborne routes. The lack of association between livestock risk factors and the more commonly detected pathogens, aEPEC and C. jejuni/coli, warrants further research, particularly to help explain how animal-keeping and sanitation practices affect transmission of fecal pathogens that were highly prevalent in chicken feces.
    MeSH term(s) Animals ; Campylobacter Infections/diagnosis ; Campylobacter Infections/epidemiology ; Campylobacter Infections/microbiology ; Campylobacter jejuni/growth & development ; Campylobacter jejuni/pathogenicity ; Cattle ; Chickens/microbiology ; Child, Preschool ; Cross-Sectional Studies ; Enteropathogenic Escherichia coli/growth & development ; Enteropathogenic Escherichia coli/pathogenicity ; Escherichia coli Infections/diagnosis ; Escherichia coli Infections/epidemiology ; Escherichia coli Infections/microbiology ; Feces/microbiology ; Ghana ; Goats ; Humans ; Infant ; Livestock/microbiology ; Logistic Models ; Milk/microbiology ; Ruminants/microbiology ; Salmonella/growth & development ; Salmonella/pathogenicity ; Salmonella Infections/diagnosis ; Salmonella Infections/epidemiology ; Salmonella Infections/microbiology ; Sheep ; Shiga-Toxigenic Escherichia coli/growth & development ; Shiga-Toxigenic Escherichia coli/pathogenicity
    Language English
    Publishing date 2021-11-29
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2942-7
    ISSN 1476-1645 ; 0002-9637
    ISSN (online) 1476-1645
    ISSN 0002-9637
    DOI 10.4269/ajtmh.21-0550
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Role of nuclear architecture in epigenetic alterations in cancer.

    Easwaran, H P / Baylin, S B

    Cold Spring Harbor symposia on quantitative biology

    2011  Volume 75, Page(s) 507–515

    Abstract: It is widely accepted that cancer results from an array of epigenetic and genetic alterations, particularly aberrant epigenetic patterns that are a hallmark of every cancer type studied. Another well-known feature of cancer cells is the array of ... ...

    Abstract It is widely accepted that cancer results from an array of epigenetic and genetic alterations, particularly aberrant epigenetic patterns that are a hallmark of every cancer type studied. Another well-known feature of cancer cells is the array of abnormalities in their nuclear structure. Although it is known that nuclear structure has an important role in the regulation of gene expression, we know little about the direct relationship between nuclear structural alterations and aberrant epigenetic patterns in cancer. Here, we discuss some of the recent studies from our lab and others to understand the relationship between alterations of nuclear architecture and aberrant epigenetic patterns in cancer cells. Although the precise relationship remains elusive, we suggest that changes in nuclear structure and composition could alter long-range genomic interactions and cause global epigenetic changes during tumorigenesis. We emphasize the need for further studies to elucidate the direct relationship between nuclear structure alterations and aberrant epigenetic patterns in cancers.
    MeSH term(s) Animals ; Cell Nucleus/chemistry ; Cell Nucleus/genetics ; Epigenesis, Genetic ; Gene Expression Regulation, Neoplastic ; Humans ; Models, Genetic ; Neoplasms/genetics ; Neoplasms/pathology ; Nuclear Proteins/metabolism
    Chemical Substances Nuclear Proteins
    Language English
    Publishing date 2011-03-29
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ISSN 1943-4456 ; 0091-7451
    ISSN (online) 1943-4456
    ISSN 0091-7451
    DOI 10.1101/sqb.2010.75.031
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Cancer-like epigenetic derangements of human pluripotent stem cells and their impact on applications in regeneration and repair.

    Huo, Jeffrey S / Baylin, Stephen B / Zambidis, Elias T

    Current opinion in genetics & development

    2014  Volume 28, Page(s) 43–49

    Abstract: A growing body of work has raised concern that many human pluripotent stem cell (hPSC) lines possess tumorigenic potential following differentiation to clinically relevant lineages. In this review, we highlight recent work characterizing the spectrum of ... ...

    Abstract A growing body of work has raised concern that many human pluripotent stem cell (hPSC) lines possess tumorigenic potential following differentiation to clinically relevant lineages. In this review, we highlight recent work characterizing the spectrum of cancer-like epigenetic derangements in human embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPSC) that are associated with reprogramming errors or prolonged culture that may contribute to such tumorigenicity. These aberrations include cancer-like promoter DNA hypermethylation and histone marks associated with pluripotency, as well as aberrant X-chromosome regulation. We also feature recent work that suggests optimized high-fidelity reprogramming derivation methods can minimize cancer-associated epigenetic aberrations in hPSC, and thus ultimately improve the ultimate clinical utility of hiPSC in regenerative medicine.
    MeSH term(s) Animals ; Cell Differentiation ; Epigenomics ; Humans ; Neoplasms/genetics ; Neoplasms/pathology ; Pluripotent Stem Cells/pathology ; Regenerative Medicine ; Wound Healing
    Language English
    Publishing date 2014-10
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1077312-5
    ISSN 1879-0380 ; 0959-437X
    ISSN (online) 1879-0380
    ISSN 0959-437X
    DOI 10.1016/j.gde.2014.09.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top